TP53 and breast carcinoma: While this is consistent with the comparable lung tumor development kinetics reported for p53-null and mutant mice (Jackson et al. 2005), it is in striking contrast to data from PDAC (Weissmueller et al. 2014) and breast cancer (Freed-Pastor et al. 2012) models.